SEC 13F Intelligence

Running Oak Capital LLC / ABT

Running Oak Capital LLC’s Abbott Laboratories Position

Does Running Oak Capital LLC own Abbott Laboratories (ABT)? Not currently — the last reported position was 55.8K shares worth $6M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q1 2023
Shares
55.8K
% of Portfolio
+1.61%
Quarters Held
7
position exited

Position History ABT

Reported value by quarter
Q3 ’20: $5MQ3 ’20Q4 ’20: $5MQ4 ’20Q1 ’21: $6MQ1 ’21Q2 ’21: $6MQ2 ’21Q3 ’22: $5MQ3 ’22Q4 ’22: $6MQ4 ’22Q1 ’23: $6MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202355.8K$6M+1.61%
Q4 202256.0K$6M+1.81%
Q3 202251.5K$5M+1.72%
Q2 202148.2K$6M+3.09%
Q1 202147.4K$6M+1.73%
Q4 202044.2K$5M+1.62%
Q3 202045.5K$5M+1.80%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Running Oak Capital LLC’s full portfolio or all institutional holders of ABT.